Carnitor 1g chewable tablets

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

L-Carnitine

Inapatikana kutoka:

Logixx Pharma Solutions Ltd

ATC kanuni:

A16AA01

INN (Jina la Kimataifa):

L-Carnitine

Kipimo:

1gram

Dawa fomu:

Chewable tablet

Njia ya uendeshaji:

Oral

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 09080100

Taarifa za kipeperushi

PACKAGE LEAFLET: INFORMATION FOR THE USER
CARNITOR 1 G CHEWABLE TABLETS
(levocarnitine)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4
.
-
In this leaflet Carnitor 1 g Chewable Tablets are called Carnitor
chewable tablets.
WHAT IS IN THIS LEAFLET:
1.
What Carnitor chewable tablets are and what they are used for
2.
What you need to know before you take Carnitor chewable tablets
3.
How to take Carnitor chewable tablets
4.
Possible side effects
5.
How to store Carnitor chewable tablets
6.
Contents of the pack and other information
1.
WHAT CARNITOR CHEWABLE TABLETS ARE AND WHAT THEY ARE USED FOR
Carnitor chewable tablets contain levocarnitine which is a type of
protein. They are used to treat primary
and secondary carnitine deficiency in adults and children over 12
years of age.
Carnitine deficiency occurs when the body has a shortage of
levocarnitine. Carnitor chewable tablets make
up for your body’s lack of levocarnitine and help give your body
more energy.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CARNITOR CHEWABLE TABLETS
_ _
DO NOT TAKE CARNITOR CHEWABLE TABLETS:
-
if you are allergic to levocarnitine or any of the other ingredients
of this medicine (listed in section 6.)
WARNINGS AND PRECAUTIONS
Tell your doctor before taking Carnitor chewable tablets if:
-
you have severe kidney problems or kidney disease and are having
dialysis
-
you are diabetic and taking insulin, or any other drug to treat your
diabetes
-
you are on a diet to reduce calorie intake
-
you have an intolerance to some sugars
-
you are taking anticoagulant

Tabia za bidhaa

OBJECT 1
CARNITOR 1 G CHEWABLE TABLETS
Summary of Product Characteristics Updated 22-Jan-2018 | Logixx Pharma
Solutions Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Carnitor 1 g Chewable Tablets
2. Qualitative and quantitative composition
Levocarnitine 1 g
Excipient with known effect: sucrose
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
White, round, standard convex tablets, approximately 22.3 mm diameter.
4. Clinical particulars
4.1 Therapeutic indications
Indicated for the treatment of primary and secondary carnitine
deficiency in adults and children over 12
years of age.
4.2 Posology and method of administration
ADULTS AND CHILDREN OVER 12 YEARS OF AGE
The tablets should be given in divided doses.
It is advisable to monitor therapy by measuring free and acyl
carnitine levels in both plasma and urine.
THE MANAGEMENT OF INBORN ERRORS OF METABOLISM
The dosage required depends upon the specific inborn error of
metabolism concerned and the severity of